Nan Du, MD, MPH
Expertise
About
Nan Du, MD, MPH, is an instructor at Harvard Medical School and an attending physician at Boston Children’s Hospital. She received her Doctor of Medicine in 2016 from the Warren Alpert School of Medicine at Brown University and completed her pediatric residency at Yale–New Haven Hospital in 2019.
She also has a master’s in public health on clinical effectiveness, with a focus on environmental toxin exposures, health services research, and large databases. She completed her pediatric gastroenterology fellowship at Boston Children’s Hospital.
Currently, she works as a clinician scientist at Boston Children’s Hospital researching celiac disease and early infant nutrition.
Education
- Bachelor of Science (BS) in Engineering Sciences–Biomedical Engineering, Harvard University, Cambridge, Massachusetts
- Doctor of Medicine (MD) from Warren Alpert Medical School, Brown University, Providence, Rhode Island
- Residency in Pediatrics at Yale-New Haven Hospital, Yale University, New Haven, Connecticut
- Fellowship in Pediatric Gastroenterology at Boston Children's Hospital, Harvard Medical School
- Masters in Public Health (MPH) from Harvard T.H. Chan School of Public Health
Certifications
- Board-Certified in Pediatrics
Awards
- Celiac Research Young Investigator Development Award, Celiac Disease Foundation, 2024
- Eleanor and Miles Shore Faculty Development Award Fellowship, Harvard Medical School, 2023
- Anne E. Dyson Child Advocacy Award, American Academy of Pediatrics, 2018
- Gold Humanism Honor Society, 2015
Professional Organizations
- Member and Public Affairs and Advocacy Committee Member, North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN)
- Member, American Society of Nutrition
Research
Dr. Du's research has focused on the role of diet and its unintended consequences in treating medical conditions of the GI tract. She has coauthored several studies examining the nutritional quality, safety, and regulatory concerns of both imported European and U.S. infant formulas. Notably, her new work has highlighted the differences in labeling, nutritional content, and safety standards between European and U.S. formulas.
She has also spearheaded two prospective cohorts to address concerns about arsenic bioaccumulation in medically-prescribed diets involving heavy rice use, particularly for infants with aspiration that requires rice cereal thickening and children with celiac disease on gluten-free diets.